We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD (AURORA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01157715
Recruitment Status : Completed
First Posted : July 7, 2010
Last Update Posted : November 6, 2014
Beijing DMS Pharma Ltd.
The Digital Angiography Reading Center (DARC)
Information provided by (Responsible Party):
Chengdu Kanghong Biotech Co.,Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2012
  Study Completion Date : July 2012